Optimizing 340B participation compliantly while “waiting and watching” new developments
Since 1992, the 340B program has required drug manufacturers to provide eligible healthcare organizations and other covered entities with drugs to be used for these organizations’ outpatients at significantly reduced prices, with the intent of helping safety net organizations improve their financial stability. In turn, hospitals are expected to demonstrate that the savings they receive…
Legal and Regulatory Compliance
Keep up with the latest legal and regulatory developments and related subtopics of privacy and HIPAA, Medicaid and Medicare compliance, IRS matters, and the Red Flags Rule.